IP Verse

Amgen patent opposition analysis

Get complete Patent Opposition Report for Amgen

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Amgen

Explore patent oppositions filed by Amgen against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3167888Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of ComplementALEXION PHARMACEUTICALSOct 28, 2024
EP3384049Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VegfREGENERON PHARMACEUTICALSApr 22, 2024
EP3536712Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9)REGENERON PHARMACEUTICALSFeb 29, 2024
EP3345607Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSSIFI MABJul 26, 2023
EP2894165Methods And Compositions For Treating Complement-Associated DisordersALEXION PHARMACEUTICALSMay 17, 2023
EP3716992Use Of A Vegf Antagonist To Treat Angiogenic Eye DisordersREGENERON PHARMACEUTICALSMay 10, 2023
EP3230316Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization LesionBAYER HEALTHCAREOct 5, 2022
EP2825558Combination Therapy For The Treatment Of Ovarian CancerFHOFFMANN LA ROCHEFeb 17, 2020
EP2756004Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9)REGENERON PHARMACEUTICALSDec 27, 2019
EP3038647Combination Therapy For The Treatment Of GlioblastomaFHOFFMANN LA ROCHEDec 23, 2019

Latest patents of Amgen opposed by its competitors

Explore Amgen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP4209499Aug 7, 2024Charged Depth Filtration Of Antigen-Binding Proteins1
EP3819007Jul 10, 2024Dosing Regimen For Anti-Bcma Agents4
EP3926051May 8, 2024Methods For Harvesting Mammalian Cell Cultures2
EP3151882Apr 10, 2024Controllable Drug Delivery System And Method Of Use2
EP2637670Mar 13, 2024Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains2
EP4058148Mar 13, 2024Dosing Regimen For Anti-Bcma Agents6
EP3152694Mar 6, 2024Systems And Methods For Remotely Processing Data Collected By A Drug Delivery Device1
EP3615066Dec 27, 2023Formulations Of Human Anti-Rankl Antibodies, And Methods Of Using The Same1
EP2301961Dec 13, 2023Sclerostin Epitopes2
EP2445924Dec 13, 2023Capture Purification Processes For Proteins Expressed In A Non-Mammalian System2

Top competitors of Amgen